These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 6857992)
41. Location of the cistron of the tobacco mosaic virus coat protein. Richards KE; Morel MC; Nicolaieff A; Lebeurier G; Hirth L Biochimie; 1975; 57(6-7):749-55. PubMed ID: 1203319 [TBL] [Abstract][Full Text] [Related]
42. New Strategies and Methods to Study Interactions between Tobacco Mosaic Virus Coat Protein and Its Inhibitors. Li X; Chen Z; Jin L; Hu D; Yang S Int J Mol Sci; 2016 Feb; 17(3):252. PubMed ID: 26927077 [TBL] [Abstract][Full Text] [Related]
43. Chemical degradation of tobacco mosaic virus followed by infectivity assay, reverse transcription-polymerase chain reaction and gel electrophoresis. Choi CW; Park SH; Choi JK; Ryu KH; Park WM Acta Virol; 2000; 44(3):145-9. PubMed ID: 11155356 [TBL] [Abstract][Full Text] [Related]
44. Evidence that a viral replicase protein is involved in the disassembly of tobacco mosaic virus particles in vivo. Wu X; Shaw JG Virology; 1997 Dec; 239(2):426-34. PubMed ID: 9434732 [TBL] [Abstract][Full Text] [Related]
45. The uncoating of native and reconstituted TMV by dimethylsulphoxide: the polarity of stripping. Nicolaieff A; Lebeurier G; Morel MC; Hirth L J Gen Virol; 1975 Mar; 26(3):295-306. PubMed ID: 1120937 [TBL] [Abstract][Full Text] [Related]
46. Dynamic localization of two tobamovirus ORF6 proteins involves distinct organellar compartments. Gushchin VA; Lukhovitskaya NI; Andreev DE; Wright KM; Taliansky ME; Solovyev AG; Morozov SY; MacFarlane SA J Gen Virol; 2013 Jan; 94(Pt 1):230-240. PubMed ID: 23052393 [TBL] [Abstract][Full Text] [Related]
47. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765 [TBL] [Abstract][Full Text] [Related]
48. Protection against tobacco mosaic virus infection in transgenic plants requires accumulation of coat protein rather than coat protein RNA sequences. Powell PA; Sanders PR; Tumer N; Fraley RT; Beachy RN Virology; 1990 Mar; 175(1):124-30. PubMed ID: 2309438 [TBL] [Abstract][Full Text] [Related]
49. Translation in vitro of artificially produced fragments of a tobamovirus genome. Skotnicki A; Gibbs A; Shaw DC Intervirology; 1976; 7(4-5):272-83. PubMed ID: 1010714 [TBL] [Abstract][Full Text] [Related]
50. Modification of tobacco mosaic virus by polyornithine and lecithin. Kiho Y; Abe T Microbiol Immunol; 1980; 24(7):617-28. PubMed ID: 7412596 [TBL] [Abstract][Full Text] [Related]
51. [Directed fragmentation of tobacco mosaic virus RNA: excision of 3' terminal sections, containing coat protein genes of tobacco mosaic virus]. Rodionova NP; Karpova OV; Metelev VG; Bogdanova SL; Shabarova ZA Mol Biol (Mosk); 1983; 17(4):809-17. PubMed ID: 6312287 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of in vitro cotranslational disassembly of tobacco mosaic virus by monoclonal antibodies to the viral coat protein. Saunal H; Witz J; Van Regenmortel MH J Gen Virol; 1993 May; 74 ( Pt 5)():897-900. PubMed ID: 8492095 [TBL] [Abstract][Full Text] [Related]
54. The role of the 5'-cap structure in viral ribonucleoproteins assembly from potato virus X coat protein and RNAs. Petrova EK; Nikitin NA; Protopopova AD; Arkhipenko MV; Yaminsky IV; Karpova OV; Atabekov JG Biochimie; 2013 Dec; 95(12):2415-22. PubMed ID: 24036171 [TBL] [Abstract][Full Text] [Related]
55. An umbraviral protein, involved in long-distance RNA movement, binds viral RNA and forms unique, protective ribonucleoprotein complexes. Taliansky M; Roberts IM; Kalinina N; Ryabov EV; Raj SK; Robinson DJ; Oparka KJ J Virol; 2003 Mar; 77(5):3031-40. PubMed ID: 12584328 [TBL] [Abstract][Full Text] [Related]
56. Exogenous application of double-stranded RNA molecules from TMV p126 and CP genes confers resistance against TMV in tobacco. Konakalla NC; Kaldis A; Berbati M; Masarapu H; Voloudakis AE Planta; 2016 Oct; 244(4):961-9. PubMed ID: 27456838 [TBL] [Abstract][Full Text] [Related]
57. Assembly of tobacco mosaic virus in vitro. Improved model for the elongation process by protein subunits. Okada Y; Ohno T; Nonomura Y J Biochem; 1975 Jun; 77(6):1157-63. PubMed ID: 1225901 [TBL] [Abstract][Full Text] [Related]
58. [Optical rotatory dispersion by 5 viruses of the tobacco mosaic virus group and their components]. Dobrov EN; Kust SV; Novikov VK; Tikhonenko TI Mol Biol (Mosk); 1978; 12(1):148-56. PubMed ID: 634280 [TBL] [Abstract][Full Text] [Related]
59. Fate of tobacco mosaic virus after entering the host cell. III. Partial uncoating. Hayashi T Microbiol Immunol; 1977; 21(6):317-24. PubMed ID: 909456 [TBL] [Abstract][Full Text] [Related]
60. β-structure of the coat protein subunits in spherical particles generated by tobacco mosaic virus thermal denaturation. Dobrov EN; Nikitin NA; Trifonova EA; Parshina EY; Makarov VV; Maksimov GV; Karpova OV; Atabekov JG J Biomol Struct Dyn; 2014; 32(5):701-8. PubMed ID: 24404770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]